[go: up one dir, main page]

CL2012003434A1 - Dermatological composition comprising a combination of: 0.1-1% copper oxide; 0.1-1% zinc oxide; 0.1-2% of calendula extract (calenduls spp) and between 0.1-2% of matico extract (buddleja globosa); use in the treatment and prevention of foot conditions. - Google Patents

Dermatological composition comprising a combination of: 0.1-1% copper oxide; 0.1-1% zinc oxide; 0.1-2% of calendula extract (calenduls spp) and between 0.1-2% of matico extract (buddleja globosa); use in the treatment and prevention of foot conditions.

Info

Publication number
CL2012003434A1
CL2012003434A1 CL2012003434A CL2012003434A CL2012003434A1 CL 2012003434 A1 CL2012003434 A1 CL 2012003434A1 CL 2012003434 A CL2012003434 A CL 2012003434A CL 2012003434 A CL2012003434 A CL 2012003434A CL 2012003434 A1 CL2012003434 A1 CL 2012003434A1
Authority
CL
Chile
Prior art keywords
extract
prevention
treatment
combination
calenduls
Prior art date
Application number
CL2012003434A
Other languages
Spanish (es)
Inventor
Venegas Marco Antonio García
Original Assignee
Garcia Venegas Marco Antonio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Garcia Venegas Marco Antonio filed Critical Garcia Venegas Marco Antonio
Priority to CL2012003434A priority Critical patent/CL2012003434A1/en
Publication of CL2012003434A1 publication Critical patent/CL2012003434A1/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

Composición dermatológica que comprende una combinación de óxido de cobre, óxido de zinc, extracto de caléndula y extracto de matico como componentes activos; y su uso en el tratamiento o prevención de afecciones de la piel, tales como infección por bacterias, por hongos, por virus, acné y psoriasis.Dermatological composition comprising a combination of copper oxide, zinc oxide, calendula extract and matic extract as active components; and its use in the treatment or prevention of skin conditions, such as infection by bacteria, fungi, viruses, acne and psoriasis.

CL2012003434A 2012-12-05 2012-12-05 Dermatological composition comprising a combination of: 0.1-1% copper oxide; 0.1-1% zinc oxide; 0.1-2% of calendula extract (calenduls spp) and between 0.1-2% of matico extract (buddleja globosa); use in the treatment and prevention of foot conditions. CL2012003434A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CL2012003434A CL2012003434A1 (en) 2012-12-05 2012-12-05 Dermatological composition comprising a combination of: 0.1-1% copper oxide; 0.1-1% zinc oxide; 0.1-2% of calendula extract (calenduls spp) and between 0.1-2% of matico extract (buddleja globosa); use in the treatment and prevention of foot conditions.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2012003434A CL2012003434A1 (en) 2012-12-05 2012-12-05 Dermatological composition comprising a combination of: 0.1-1% copper oxide; 0.1-1% zinc oxide; 0.1-2% of calendula extract (calenduls spp) and between 0.1-2% of matico extract (buddleja globosa); use in the treatment and prevention of foot conditions.

Publications (1)

Publication Number Publication Date
CL2012003434A1 true CL2012003434A1 (en) 2013-05-31

Family

ID=52012159

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012003434A CL2012003434A1 (en) 2012-12-05 2012-12-05 Dermatological composition comprising a combination of: 0.1-1% copper oxide; 0.1-1% zinc oxide; 0.1-2% of calendula extract (calenduls spp) and between 0.1-2% of matico extract (buddleja globosa); use in the treatment and prevention of foot conditions.

Country Status (1)

Country Link
CL (1) CL2012003434A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9936705B2 (en) 2014-06-16 2018-04-10 Biogenesis Animal Health Biocide formulation for protecting the skin, comprising pentahydrate copper salts and heptahydrate zinc salts

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9936705B2 (en) 2014-06-16 2018-04-10 Biogenesis Animal Health Biocide formulation for protecting the skin, comprising pentahydrate copper salts and heptahydrate zinc salts

Similar Documents

Publication Publication Date Title
ECSP12012310A (en) 5-FLUORO-1H-REPLACED PIRAZOLOPIRIDINES AND ITS USE
MX383908B (en) Topical sanitizing formulations and uses thereof
DOP2011000285A (en) 2-ACETAMIDO-5-ARIL-1, 2, 4-SUBSTITUTED TRIAZOLONS AND ITS USE
CL2016001547A1 (en) Compositions for oral care
BR112014006455A2 (en) alkylamidothiazoles, cosmetic or dermatological preparations having a content of one or more alkylamidothiazoles and use of one or more alkylamidothiazoles
MX2018011249A (en) TOPICAL NON-AQUEOUS COMPOSITIONS INCLUDING A HALOGENATED SALICILANILIDE.
BR112016006048A8 (en) antimicrobial compositions
CR20140579A (en) HERBICIDE COMPOSITION THAT HAS IMPROVED HERBICITY ACTIVITY
CL2016000544A1 (en) Cosmetic composition comprising 0.0001 to 10% by weight of guacatonga extract (casearia sylvestris) and 0.00005 to 10% by weight of aroeira extract (schinus terebinthifolius raddi) both with respect to the total weight of the composition; use of the composition in the prevention and / or treatment of signs of skin aging; method to prevent and / or treat the signs of skin aging.
MX2017004998A (en) Composition containing extract or fraction of genus justicia plant.
CL2018001104A1 (en) Composition for skin care and associated procedure.
CL2016002879A1 (en) Pharmaceutical compositions for treating infectious diseases
MX2015003074A (en) Formulations comprising idebenone, n-acetyl-s-farnesyl-l-cysteine and ergothioneine and uses thereof.
WO2016030899A8 (en) Methods of treating amyotrophic lateral scleroses
UY34985A (en) ANTISÉPTICA, ANTISEBORREICA AND EXFOLIATING COMPOSITION TO ELIMINATE OR PREVENT ACNE.
CL2015001748A1 (en) Transdermic Antiparasitic Formulations
MX336204B (en) A COMPOSITION AND USE OF THE SAME IN THE TREATMENT OF ANAL RAGADES.
HK1220138A1 (en) Composition for skin anti-ageing treatment
CL2012003250A1 (en) Use of a galactolipid in combination with ascorbic acid and / or a derivative thereof that serves to protect a composition against oxidation; method for the preparation of the composition, composition; and product.
CL2012003434A1 (en) Dermatological composition comprising a combination of: 0.1-1% copper oxide; 0.1-1% zinc oxide; 0.1-2% of calendula extract (calenduls spp) and between 0.1-2% of matico extract (buddleja globosa); use in the treatment and prevention of foot conditions.
CL2010000987A1 (en) Alcoholic extract of avocado cuesco consisting of avocadofuran type compounds derived from the American Persian avocado mill; use of the extract as acaricide against or. yothersi, t. cinnabarinus and p. citri, and insecticide against t. vaporariorum.
CN105682672A8 (en) Composition for inhibiting neuraminidase activity comprising geranylflavone from paulownia tomentosa as active ingredient
BR112015020182A2 (en) cosmetic use of cheuin or a precursor or derivative thereof as an active ingredient, use of cheuin or a precursor or derivative thereof as an active ingredient, cosmetic composition and cosmetic treatment process to prevent and / or treat signs of skin aging and / or cutaneous attachments
AR082594A1 (en) PANTENYL DOCOSAHEXANOATE AND ITS USE FOR THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES
BR112015002984A2 (en) composition, vaccine to protect an animal against infection with leptospira bacteria, and use of citric acid.